enters

FAGE ENTERS GLOBAL PARTNERSHIP WITH FERRARI HYPERCAR IN THE FIA WORLD ENDURANCE CHAMPIONSHIP

STRASSEN, Luxembourg, Nov. 5, 2025 /PRNewswire/ -- FAGE International S.A. (the "Company" or "FAGE") a leading international Greek yogurt company,…

3 months ago

PartnerOne Enters Agreement to Acquire Mortgage Cadence

RIVERSIDE, Calif., Oct. 28, 2025 /PRNewswire/ -- PartnerOne, one of the fastest-growing software groups in the world, has entered into…

4 months ago

Jiuzi Holdings, Inc Enters Strategic Partnership with BitFi to Advance Bitcoin-Centric Finance

HANGZHOU, China, Oct. 20, 2025 /PRNewswire/ -- Jiuzi Holdings, Inc. (NASDAQ: JZXN; the "Company") today formally announced it has signed…

4 months ago

Bybit Georgia Enters New Chapter with Presence at DGFI 2025 and Major Partnership Deal with Setanta Sports

TBILISI, Georgia, Oct. 15, 2025 /PRNewswire/ -- Bybit Georgia, a crypto exchange (VASP) licensed by the National Bank of Georgia…

4 months ago

Zeta Network Group Enters Strategic Partnership with SOLV Foundation to Advance Bitcoin-Centric Finance

NEW YORK, Oct. 7, 2025 /PRNewswire/ -- Zeta Network Group (Nasdaq: ZNB) (the "Company") today announced it has entered into…

4 months ago

IDEMIA Secure Transactions Enters the $1.2B Hardware Security Module Market with a Revolutionary, Sovereign, and Energy-Efficient Solution

IDEMIA Secure Transactions (IST) breaks new ground in cybersecurity with IDEMIA Sphere HSM launch. This strategic expansion marks IST's foray…

5 months ago

PacBio Enters High-Throughput Carrier Screening Market with Standalone HiFi Sequencing Assay for Challenging Genes

Enhanced PureTarget portfolio replaces the need for multiple tests with single scalable solution for inherited disease screening September 22, 2025…

5 months ago

Milano Cortina 2026 ramps up excitement as Italy enters final delivery phase

17 September 2025 - With just 70 days to go until the Olympic flame is lit in Olympia, Greece, the International…

5 months ago

Roche enters into a definitive merger agreement to acquire 89bio, and its phase 3 FGF21 analog for the therapy of moderate to severe MASH

89bio’s pegozafermin allows for a potentially best-in-disease treatment for moderate to severe Metabolic Dysfunction-Associated Steatohepatitis (MASH), one of the most…

5 months ago

NYSE Content Advisory: Pre-Market Update + S&P 500 enters week 0.8% from record

NEW YORK, Sept. 8, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…

5 months ago